SONY:NYSESony Group Corporation Analysis
Data as of 2026-09-07 - not real-time
$24.56
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Sony Group Corporation is priced at $24.56, and its moving averages give no clean directional read — the structure is neutral. It has gained 17.1% over the past 30 days. With RSI at 60.3 the momentum picture is approaching overbought, alongside a bearish MACD signal. The recent range runs from support at $23.18 up to resistance at $25.27.
On valuation the read is undervalued — earnings multiple of 21.0 versus a 33.2 sector average, below the peer group. Consensus targets land 22.1% above where the shares trade now. Revenue is growing at 8.2% on a -1.7% profit margin. The 0.65% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 30.7%, a beta of 0.75 and a maximum drawdown of 36.2%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.
On valuation the read is undervalued — earnings multiple of 21.0 versus a 33.2 sector average, below the peer group. Consensus targets land 22.1% above where the shares trade now. Revenue is growing at 8.2% on a -1.7% profit margin. The 0.65% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 30.7%, a beta of 0.75 and a maximum drawdown of 36.2%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 22.79
- MACD momentum is negative
- 30-day price change of +17.1%
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 21.0 versus sector average of 33.2
- Trading above the 200-day average of 22.79
- Analyst targets imply +22.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 21.0 versus sector average of 33.2
- Negative profit margin of -1.7%
- Analyst targets imply +22.1% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth8.20%
Profit Margin-1.75%
P/E Ratio21.0
ROE13.16%
ROA4.25%
Debt/Equity21.32
P/B Ratio2.7
Op. Cash Flow$2065.7B
Free Cash Flow$3351.3B
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI60.3
Support$23.18
Resistance$25.27
MA 20$24.09
MA 50$22.53
MA 200$22.79
MACDBearish
VolumeStable
Fear & Greed Index95.48
Valuation
Fair Value$10,324.47
Target Price$30.00
Upside/Downside22.15%
GradeUndervalued
TypeBlend
Dividend Yield0.65%
Risk Assessment
Beta0.75
Volatility30.65%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.